'Fasting pathway' points the way to new class of diabetes drugs

A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.

Read the whole article on Physorg

More from Physorg